As reported by the Washington Post, Johnson & Johnson is recalling over 33,000 bottles of baby powder after the U.S. Food and Drug Administration found small amounts of asbestos in a bottle purchased online.
As reported by Law360 a Mississippi state judge has denied an attempt by Johnson & Johnson J&J to throw out a first-of-its-kind class action injury lawsuit filed by the state’s attorney general. The suit alleges the pharmaceutical giant is putting tens of thousands of women at risk by failing to disclose that the use of its talcum powder products can lead to ovarian cancer. [Read more…]
A recent in-depth investigation published by Reuters reveals Johnson and Johnson knew for decades that its talc products like baby powder include asbestos fibers, and that exposure to those fibers can lead to ovarian cancer. The revelation caused J&J shares to drop 10% resulting in a $45 billion reduction in value for the company. This newest drop follows a July 2018 jury ruling that ordered J&J to pay $4.69 billion to women who claimed asbestos in J&J body products caused them to develop cancer. [Read more…]
The first case to formally allege a link between asbestos and Johnson & Johnson’s talcum powder causing ovarian cancer recently won a verdict of $4.69 billion at trial. The award included individual payments for each of the 22 plaintiffs, with a staggering $4.14 billion in punitive damages against J&J. As noted by Law360, “experts say [this] novel approach could represent a new stage for the myriad suits alleging talcum powder causes cancer.” [Read more…]
$4.1 billion in punitive damages against the company for covering up testing data and scientific studies it knew showed the cosmetic-grade talc contained asbestos
A Missouri federal court has ordered Johnson & Johnson to pay an extraordinary $4.7 billion to a group of injured women who alleged that talc products sold by J&J led them to develop ovarian cancer. The women had claimed the company’s talcum powder products contained asbestos and gave cancer to 22 women, six of whom have already died. [Read more…]
The New York Times reports that as of July 2017, 4,800 women are suing pharmaceutical and consumer products giant Johnson & Johnson (J&J) over ovarian cancer injuries allegedly caused by long-term use of J&J’s talc baby powder products. According to the paper, unlike many large-scale injury cases, “the plaintiffs [in talc] are not working as a team. They are taking the company to court one at a time.” [Read more…]
A $417 million verdict has been awarded against Johnson & Johnson in the first California state jury trial on claims that the company’s talcum powder products were linked to plaintiff Eva Echeverria’s terminal ovarian cancer. [Read more…]
Judge Maren Nelson of Los Angeles Superior Court has scheduled an early July trial for the first California injury lawsuit against Johnson & Johnson over ovarian cancer allegedly caused by the long-term use of the company’s talcum powder. The trial will be the first in the coordinated proceedings involving over 300 injured women who all claim they developed ovarian cancer as a result of talc use. [Read more…]
As reported by Law360 (subscription), a Texas jury has found Johnson & Johnson’s DePuy Orthopedics liable for over $1 billion in a federal 6-plaintiff bellwether trial over injurious metal-on-metal Pinnacle hip implants causing metal poisoning and other injuries to implant recipients. The jury deliberated for less than a day in finding negligence in design and a failure to warn surgeons and patients about the dangers of the metal-component Pinnacle hip implants. The verdict is more than six times greater than the $150 million reached in a previous bellwether trial against J&J on these hip implant injuries. [Read more…]
Law360 notes that multiple trial victories in Missouri state court totaling $200 million against Johnson & Johnson’s talc baby powder product have shed light on the seeming parallels between the litigation on talc injuries and the long-running cases against tobacco companies. It seems in both instances, misleading product advertising and failures to adequately inform the public of product health risks were tragic way stations on paths that led to serious personal injuries and wrongful deaths. [Read more…]
As reported by Law360 (subscription), U.S. District Court Judge Ed Kinkeade has reduced a $496 million judgment against Johnson & Johnson’s DePuy Orthopaedics in five combined Pinnacle implant hip injury bellwether trials to keep the amount in line with the Texas punitive damages cap. Attorneys in the case indicate the new overall amount assessed against DePuy for its allegedly defective and dangerous Pinnacle hip implants will be closer to $150 million. A jury in the consolidated trial in Dallas had found the companies liable for serious health problems, including bone erosion and metal poisoning, that plaintiffs claimed were directly related to the metal-on-metal hip implants. Judge Kinkeade lowered the $360 million punitive damages award by $350 million in the face of Texas’ statutory $10 million limit on punitive damages. [Read more…]
New Jersey-based health care company Johnson & Johnson has lost two trials in St. Louis over claims its talcum baby powder product is linked to ovarian cancer. The verdicts total $127 million – $55 million was awarded to plaintiff Gloria Ristesund in May 2016 and $72 million to the estate of Jacqueline Fox in February. [Read more…]
U.S. District Judge Ed Kinkeade has selected seven DePuy hip injury bellwether cases to proceed to trial in the multidistrict injury litigation against Johnson & Johnson’s DePuy Orthopaedics Inc. unit. J&J had asked Judge Kinkeade to stay (pause) the cases pending J&J’s appeal of a previous $497.6 million injury-related verdict against the company, but he refused, slating the 7 bellwether cases to begin trials starting September 6, 2016. The other 8,800 cases in the MDL will be put on hold until all of the bellwether trials take place. [Read more…]
As reported today by Law360 (subscription), the jury in the second bellwether trial multidistrict litigation over allegedly defective Pinnacle hip prosthetics manufactured by Johnson & Johnson’s DePuy Orthopaedics Inc. unit reached a verdict of $497.6 million on a judgment for the plaintiffs in consolidated claims relating to five separate hip implant patients.
Medical device manufacturer Johnson & Johnson (J&J) has agreed to pay a $120 million settlement to the 2-3,000 women who filed injury lawsuits claiming to have suffered organ damage and constant pain from allegedly dangerous and defective surgical mesh. As reported by Bloomberg, these “settlements mark the first time J&J and its Ethicon unit have agreed to resolve a significant number of mesh cases.” [Read more…]
The story behind a drug called Risperdal has a long and winding tail. And it is a story that has had devastating results for many American families.
A Philadelphia jury returned a $2.5 million verdict against healthcare giant Johnson & Johnson for a 20-year-old autistic man from Alabama who allegedly developed large breasts as a teenager while prescribed the antipsychotic medication Risperdal. The lawsuit charged that Johnson & Johnson failed to warn consumers of the distressing side effects that Risperdal causes, concealing from officials the dangerous and defective risks involved when taking the prescribed medication.